Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig00501 |
small subunit processome component |
1552 |
20 |
3.81E-159 |
78.25% |
3 |
C:small nucleolar ribonucleoprotein complex; F:protein binding; P:rRNA processing |
|
|
contig00502 |
ornithine decarboxylase antizyme |
1246 |
20 |
3.17E-72 |
79.95% |
3 |
P:polyamine biosynthetic process; F:ornithine decarboxylase inhibitor activity; F:protein binding |
|
|
contig00503 |
eukaryotic translation initiation factor 4e binding protein 1 |
960 |
20 |
4.66E-43 |
75.30% |
6 |
F:translation repressor activity; P:insulin receptor signaling pathway; P:negative regulation of protein complex assembly; P:negative regulation of translational initiation; C:cytoplasm; F:eukaryotic initiation factor 4E binding |
|
|
contig00504 |
interleukin enhancer-binding factor 3 homolog |
589 |
20 |
9.48E-90 |
89.35% |
9 |
F:transcription repressor activity; F:double-stranded RNA binding; F:transcription activator activity; F:protein binding; F:transcription factor activity; P:transcription antitermination; P:negative regulation of transcription, DNA-dependent; P:positive regulation of transcription, DNA-dependent; C:nucleus |
|
|
contig00505 |
interleukin enhancer-binding factor 3 homolog |
214 |
15 |
3.45E-07 |
85.67% |
9 |
C:nucleus; F:DNA binding; F:double-stranded RNA binding; F:RNA binding; P:regulation of transcription, DNA-dependent; C:intracellular; P:transcription termination; P:transcription antitermination; P:transcription |
|
|
contig00506 |
zinc finger protein 135 |
477 |
20 |
1.52E-95 |
55.15% |
1 |
F:binding |
|
|
contig00507 |
survival motor neuron domain containing 1 |
1013 |
20 |
3.38E-111 |
87.25% |
7 |
P:induction of apoptosis; P:spliceosome assembly; C:nuclear speck; F:protein binding; C:spliceosomal complex; ; C:cytoplasm |
|
|
contig00508 |
macrophage migration inhibitory factor |
663 |
20 |
1.15E-50 |
90.70% |
9 |
P:prostaglandin biosynthetic process; P:inflammatory response; P:cell surface receptor linked signaling pathway; F:cytokine activity; C:extracellular space; F:phenylpyruvate tautomerase activity; P:cell proliferation; P:negative regulation of apoptosis; C:cytoplasm |
EC:5.3.2.1 |
|
contig00509 |
---NA--- |
265 |
0 |
|
|
0 |
|
|
|
contig00510 |
hypothetical protein Kpol_464p3 [Vanderwaltozyma polyspora DSM 70294] |
559 |
1 |
2.38E-04 |
62.00% |
0 |
|
|
|
contig00511 |
proteasome ( macropain) 26s non- 14 |
960 |
20 |
5.70E-150 |
91.55% |
5 |
F:endopeptidase activity; F:protein binding; P:ubiquitin-dependent protein catabolic process; C:proteasome complex; C:cytosol |
|
|
contig00512 |
---NA--- |
126 |
0 |
|
|
0 |
|
|
|
contig00513 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig00514 |
---NA--- |
1224 |
0 |
|
|
0 |
|
|
|
contig00515 |
integrator complex subunit 12 |
393 |
20 |
1.94E-21 |
82.95% |
5 |
F:protein binding; P:zinc ion transport; P:snRNA processing; F:zinc ion binding; C:integrator complex |
|
|
contig00516 |
family with sequence similarity member a |
329 |
20 |
9.72E-50 |
84.10% |
1 |
F:F |
|
|
contig00517 |
---NA--- |
450 |
0 |
|
|
0 |
|
|
|
contig00518 |
f11 receptor |
1211 |
20 |
6.02E-36 |
62.00% |
3 |
P:cellular process; C:cell junction; F:protein binding |
|
|
contig00519 |
---NA--- |
161 |
0 |
|
|
0 |
|
|
|
contig00520 |
elac homolog 2 |
736 |
20 |
1.14E-71 |
79.55% |
5 |
F:endonuclease activity; F:protein binding; C:nucleus; F:zinc ion binding; P:tRNA processing |
|
|
contig00521 |
PREDICTED: hypothetical protein [Danio rerio] |
1754 |
1 |
3.19E-10 |
58.00% |
0 |
|
|
|
contig00522 |
calcyclin binding protein |
1560 |
20 |
7.58E-77 |
78.80% |
3 |
C:cytoplasm; C:nuclear envelope lumen; P:ubiquitin cycle |
|
|
contig00523 |
mucolipin 2 |
1751 |
20 |
2.84E-176 |
79.05% |
7 |
C:cytoplasm; C:plasma membrane; P:cation transport; C:integral to membrane; F:cation channel activity; P:locomotory behavior; P:auditory receptor cell differentiation |
|
|
contig00524 |
---NA--- |
784 |
0 |
|
|
0 |
|
|
|
contig00525 |
coiled-coil domain containing 16 |
1375 |
20 |
2.07E-51 |
78.60% |
2 |
P:cell cycle; P:multicellular organismal development |
|
|
contig00526 |
---NA--- |
418 |
0 |
|
|
0 |
|
|
|
contig00527 |
ribosomal protein l8 |
823 |
20 |
1.67E-141 |
99.05% |
4 |
F:structural constituent of ribosome; C:cytosolic large ribosomal subunit; P:translation; F:rRNA binding |
EC:3.6.5.3 |
|
contig00528 |
pescadillo homolog containing brct domain |
1395 |
20 |
1.34E-130 |
81.60% |
5 |
C:nucleolus; P:cell proliferation; P:nucleolus organization; P:mitotic metaphase; C:condensed chromosome |
|
|
contig00529 |
h+ lysosomal v0 subunit d1 |
894 |
20 |
7.41E-109 |
96.70% |
5 |
P:proton transport; F:proton-transporting ATPase activity, rotational mechanism; C:vacuolar proton-transporting V-type ATPase complex; F:hydrogen-exporting ATPase activity, phosphorylative mechanism; F:hydrogen ion transporting ATP synthase activity, rotational mechanism |
EC:3.6.3.14; EC:3.6.3.6 |
|
contig00530 |
---NA--- |
311 |
0 |
|
|
0 |
|
|
|
contig00531 |
---NA--- |
211 |
0 |
|
|
0 |
|
|
|
contig00532 |
disrupter of silencing 10 |
2016 |
20 |
1.68E-120 |
73.60% |
4 |
C:nucleolus; P:organelle organization; F:protein binding; P:brain development |
|
|
contig00533 |
---NA--- |
171 |
0 |
|
|
0 |
|
|
|
contig00534 |
syntaxin 2 |
1727 |
20 |
1.43E-63 |
71.10% |
12 |
P:cytokinesis; C:soluble fraction; P:embryo implantation; C:integral to membrane; P:acrosome reaction; P:organ morphogenesis; C:microsome; P:cell differentiation; F:calcium-dependent protein binding; P:signal transduction; P:ectoderm development; C:basolateral plasma membrane |
|
|
contig00535 |
chromosome 9 open reading frame 64 |
511 |
20 |
1.10E-25 |
72.80% |
2 |
F:F; C:C |
|
|
contig00536 |
eukaryotic translation initiation factor 4e binding protein 1 |
250 |
20 |
2.38E-16 |
78.35% |
6 |
C:cytoplasm; P:negative regulation of translational initiation; F:translation initiation factor activity; F:eukaryotic initiation factor 4E binding; F:translation repressor activity; P:insulin receptor signaling pathway |
|
|
contig00537 |
karyopherin alpha 2 (rag cohort importin alpha 1) |
1812 |
20 |
0 |
85.95% |
6 |
F:protein transporter activity; P:regulation of transcription by glucose; P:protein import into nucleus; C:nuclear pore; F:protein binding; C:cytoplasm |
|
|
contig00538 |
---NA--- |
791 |
0 |
|
|
0 |
|
|
|
contig00539 |
zinc finger protein 143 |
256 |
20 |
6.67E-22 |
63.95% |
3 |
F:zinc ion binding; F:nucleic acid binding; C:intracellular |
|
|
contig00540 |
---NA--- |
470 |
0 |
|
|
0 |
|
|
|
contig00541 |
---NA--- |
281 |
0 |
|
|
0 |
|
|
|
contig00542 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
contig00543 |
small nuclear rna activating polypeptide 43kda |
1286 |
20 |
1.22E-88 |
58.30% |
1 |
P:transcription |
|
|
contig00544 |
ly1 antibody reactive homolog |
1389 |
20 |
5.89E-70 |
64.15% |
2 |
C:nucleolus; F:protein binding |
|
|
contig00545 |
---NA--- |
364 |
0 |
|
|
0 |
|
|
|
contig00546 |
dead (asp-glu-ala-asp) box polypeptide 47 |
816 |
20 |
3.81E-122 |
96.00% |
6 |
C:cytoplasm; C:nucleolus; F:ATP-dependent RNA helicase activity; F:RNA binding; F:ATP binding; P:RNA metabolic process |
|
|
contig00547 |
---NA--- |
305 |
0 |
|
|
0 |
|
|
|
contig00548 |
coatomer protein subunit zeta 1 |
894 |
20 |
1.96E-93 |
98.40% |
9 |
C:COPI vesicle coat; F:protein transporter activity; C:clathrin vesicle coat; C:Golgi membrane; P:retrograde vesicle-mediated transport, Golgi to ER; P:intra-Golgi vesicle-mediated transport; P:protein complex assembly; F:protein binding; P:intracellular protein transport |
|
|
contig00549 |
bud31 homolog |
1057 |
20 |
1.41E-83 |
98.35% |
5 |
P:regulation of transcription from RNA polymerase II promoter; P:multicellular organismal development; F:transcription factor activity; C:nucleus; F:zinc ion binding |
|
|
contig00550 |
---NA--- |
223 |
0 |
|
|
0 |
|
|
|
contig00551 |
domain containing 1 |
354 |
20 |
1.11E-45 |
84.35% |
1 |
P:immune response |
|
|
contig00552 |
family with sequence similarity member a |
2107 |
20 |
2.71E-99 |
75.70% |
1 |
F:protein binding |
|
|
contig00553 |
arp6 actin-related protein 6 homolog |
246 |
20 |
1.88E-29 |
96.55% |
8 |
C:cytoskeleton; C:membrane; C:cytoplasm; F:receptor activity; F:structural molecule activity; F:protein binding; P:transport; F:transporter activity |
|
|
contig00554 |
atp h+ mitochondrial f1 beta polypeptide |
687 |
20 |
3.86E-92 |
97.50% |
9 |
F:hydrogen-exporting ATPase activity, phosphorylative mechanism; F:hydrogen ion transporting ATP synthase activity, rotational mechanism; C:integral to membrane; P:ATP synthesis coupled proton transport; F:metal ion binding; F:ATP binding; F:protein binding; C:mitochondrial proton-transporting ATP synthase, catalytic core; F:proton-transporting ATPase activity, rotational mechanism |
EC:3.6.3.6; EC:3.6.3.14 |
|
contig00555 |
atp synthase beta subunit |
1035 |
20 |
2.21E-136 |
90.90% |
11 |
C:proton-transporting ATP synthase complex, catalytic core F(1); F:lipoprotein receptor activity; F:hydrogen-exporting ATPase activity, phosphorylative mechanism; F:hydrogen ion transporting ATP synthase activity, rotational mechanism; C:integral to membrane; C:mitochondrial inner membrane; P:ATP synthesis coupled proton transport; F:metal ion binding; F:ATP binding; P:receptor-mediated endocytosis; F:proton-transporting ATPase activity, rotational mechanism |
EC:3.6.3.6; EC:3.6.3.14 |
|
contig00556 |
tetraspanin 7 |
452 |
20 |
4.24E-29 |
59.80% |
2 |
C:integral to membrane; C:plasma membrane |
|
|
contig00557 |
---NA--- |
765 |
0 |
|
|
0 |
|
|
|
contig00558 |
glyceraldehyde-3-phosphate dehydrogenase |
1397 |
20 |
7.18E-100 |
96.35% |
4 |
C:cytoplasm; F:NAD or NADH binding; P:glycolysis; F:glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity |
EC:1.2.1.12 |
|
contig00559 |
---NA--- |
477 |
0 |
|
|
0 |
|
|
|
contig00560 |
egg envelope component zpc |
2002 |
20 |
3.13E-73 |
49.05% |
0 |
|
|
|
contig00561 |
---NA--- |
248 |
0 |
|
|
0 |
|
|
|
contig00562 |
novel protein |
967 |
20 |
5.97E-30 |
77.00% |
2 |
F:F; C:C |
|
|
contig00563 |
high density lipoprotein-binding protein |
879 |
20 |
3.05E-67 |
95.25% |
9 |
C:cytoplasm; F:lipid transporter activity; F:lipid binding; C:plasma membrane; F:RNA binding; F:protein binding; P:lipid transport; P:cholesterol metabolic process; C:nucleus |
|
|
contig00564 |
mad2l1 binding protein |
572 |
20 |
9.84E-57 |
66.95% |
5 |
C:cytoplasm; P:mitotic cell cycle; F:protein binding; P:regulation of cell cycle; C:nucleus |
|
|
contig00565 |
---NA--- |
257 |
0 |
|
|
0 |
|
|
|
contig00566 |
---NA--- |
847 |
0 |
|
|
0 |
|
|
|
contig00567 |
---NA--- |
283 |
0 |
|
|
0 |
|
|
|
contig00568 |
---NA--- |
130 |
0 |
|
|
0 |
|
|
|
contig00569 |
cytochrome c oxidase subunit vic |
409 |
20 |
3.82E-30 |
81.90% |
4 |
C:mitochondrial inner membrane; P:electron transport; C:integral to membrane; F:cytochrome-c oxidase activity |
EC:1.9.3.1 |
|
contig00570 |
---NA--- |
805 |
0 |
|
|
0 |
|
|
|
contig00571 |
at rich interactive domain 3a (bright-like) |
544 |
20 |
5.05E-57 |
66.20% |
4 |
F:transcription factor activity; C:nucleus; F:protein homodimerization activity; P:regulation of transcription, DNA-dependent |
|
|
contig00572 |
at rich interactive domain 3b (bright-like) |
218 |
20 |
1.18E-15 |
67.40% |
2 |
F:DNA binding; C:intracellular |
|
|
contig00573 |
---NA--- |
387 |
0 |
|
|
0 |
|
|
|
contig00574 |
eh domain-containing protein 3 |
1373 |
20 |
2.95E-90 |
65.40% |
0 |
|
|
|
contig00575 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
contig00576 |
---NA--- |
408 |
0 |
|
|
0 |
|
|
|
contig00577 |
family with sequence similarity member a1 |
296 |
20 |
5.60E-13 |
79.75% |
0 |
|
|
|
contig00578 |
y box protein 2 |
1031 |
20 |
5.15E-67 |
75.50% |
10 |
F:mRNA binding; P:negative regulation of translation; P:regulation of transcription, DNA-dependent; F:lipid binding; P:spermatid development; F:DNA binding; F:translation regulator activity; C:ribonucleoprotein complex; P:oogenesis; C:cytoplasm |
|
|
contig00579 |
---NA--- |
327 |
0 |
|
|
0 |
|
|
|
contig00580 |
---NA--- |
668 |
0 |
|
|
0 |
|
|
|
contig00581 |
poly -specific ribonuclease (deadenylation nuclease) |
2681 |
20 |
0 |
83.75% |
11 |
C:cytoplasm; F:poly(A)-specific ribonuclease activity; P:female gamete generation; F:mRNA 3'-UTR binding; P:meiosis; F:protein binding; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; F:magnesium ion binding; C:nucleus; P:RNA modification; F:nucleotide binding |
EC:3.1.13.4 |
|
contig00582 |
apoptosis- taf9-like domain 1 |
826 |
20 |
1.20E-46 |
76.75% |
12 |
C:soluble fraction; C:microsome; C:intracellular organelle part; P:D-gluconate metabolic process; F:carboxylic acid binding; P:pentose-phosphate shunt, oxidative branch; F:protein binding; F:phosphogluconate dehydrogenase (decarboxylating) activity; F:NADP or NADPH binding; C:chromosome; F:sugar binding; C:nucleus |
EC:1.1.1.44 |
|
contig00583 |
leucine rich repeat containing 31 |
1321 |
20 |
7.84E-40 |
56.95% |
1 |
F:protein binding |
|
|
contig00584 |
c12orf62 homolog |
403 |
20 |
2.34E-19 |
78.40% |
1 |
C:membrane |
|
|
contig00585 |
solute carrier family member 1a |
2129 |
20 |
4.35E-97 |
76.60% |
3 |
P:transport; F:secondary active transmembrane transporter activity; C:integral to membrane |
|
|
contig00586 |
---NA--- |
117 |
0 |
|
|
0 |
|
|
|
contig00587 |
aconitase mitochondrial |
445 |
20 |
1.19E-71 |
98.95% |
6 |
P:citrate metabolic process; F:iron ion binding; P:tricarboxylic acid cycle; F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; C:mitochondrion |
EC:4.2.1.3 |
|
contig00588 |
---NA--- |
166 |
0 |
|
|
0 |
|
|
|
contig00589 |
---NA--- |
162 |
0 |
|
|
0 |
|
|
|
contig00590 |
coenzyme q6 homolog |
475 |
20 |
1.35E-59 |
87.15% |
7 |
F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen; C:extracellular space; P:electron transport; P:cellular aromatic compound metabolic process; P:ubiquinone biosynthetic process; F:FAD binding; C:mitochondrion |
EC:1.14.13.0 |
|
contig00591 |
nucleolin |
1110 |
20 |
3.13E-20 |
97.60% |
7 |
C:nucleolus; P:angiogenesis; F:DNA binding; F:RNA binding; C:cell cortex; F:protein C-terminus binding; F:nucleotide binding |
|
|
contig00592 |
novel protein |
784 |
2 |
2.61E-39 |
70.00% |
0 |
|
|
|
contig00593 |
gpn-loop gtpase 2 |
1037 |
20 |
9.74E-90 |
91.50% |
1 |
F:ATP binding |
|
|
contig00594 |
rna terminal phosphate cyclase-like 1 |
1198 |
20 |
0 |
90.20% |
3 |
C:nucleolus; P:rRNA processing; F:RNA-3'-phosphate cyclase activity |
EC:6.5.1.4 |
|
contig00595 |
---NA--- |
533 |
0 |
|
|
0 |
|
|
|
contig00596 |
---NA--- |
162 |
0 |
|
|
0 |
|
|
|
contig00597 |
---NA--- |
311 |
0 |
|
|
0 |
|
|
|
contig00598 |
---NA--- |
695 |
0 |
|
|
0 |
|
|
|
contig00599 |
extracellular matrix protein 1 |
968 |
20 |
2.41E-47 |
53.80% |
1 |
C:extracellular region part |
|
|
contig00600 |
af206632_1ring-infested erythrocyte surface antigen |
996 |
1 |
1.19E-04 |
51.00% |
0 |
|
|
|
100 Rows returned.